• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Social media narratives regarding Opill(R): public discourse analysis around the first over-the-counter birth control pill

On 13 July 2023, the United States Food and Drug Administration (FDA) approved the country’s first daily over-the-counter contraceptive pill containing norgestrel 75 μg and known by the brand name Opill®.1 Having become available to the public in early 2024, this represented an important opportunity for contraceptive access, autonomy and privacy. However, it also heightened the importance of public-facing information regarding correct use, side effects and efficacy, particularly on social media platforms which are used frequently among young adults and increasingly for discourse around healthcare.2 3 This study examined TikTok narratives on Opill® to assess the volume, content and sentiment of the product online early in its release.

A cross-sectional content analysis of publicly available TikTok videos was conducted. Using Apify, TikTok videos were scraped (programmatically collected from public sources) on 21 January 2025, using “Opill” and “O-Pill” as search terms. English language videos were…

Read the full article ›

Posted in: Journal Article Abstracts on 04/07/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice